💉 Counterfeit Ozempic: FDA Warns of Unsafe Drug Supply (4/14/2025)

The provided text, originating from the Food and Drug Administration (FDA), serves as a crucial public health warning regarding counterfeit Ozempic (semaglutide) injections found within the U.S. drug supply chain. It details multiple instances where fake versions of the medication were identified and seized, highlighting specific lot and serial numbers to help consumers, pharmacies, and healthcare professionals identify these fraudulent products. The […]

🔥 Drink This Before Bed — It Forces Belly Fat to Burn Overnight | Dr. Mandell

If you’re struggling with stubborn belly fat, especially as you age, this simple nighttime drink may help reset your body’s fat-burning hormones while you sleep. It’s a natural, science-backed mix of Matcha, cinnamon, apple cider vinegar, and lemon is designed to work with your metabolism, not against it. Matcha stimulates thermogenesis and gently raises your […]

Caution is prescribed for American Academy of Paediatrics’ guidelines on weight loss medications for childhood obesity

Prescribing glucagon-like peptide 1 (GLP-1) receptor agonists such as semaglutide or tirzepatide for weight loss has created vigorous scientific debate. Four recent reviews in The BMJ conclude that GLP-1 agonists are highly effective for weight loss and may improve outcomes in people with conditions associated with obesity.1234 Yet concerns exist about their side effects,1234 safety […]

Obesity drug prices are dropping, but getting a steady supply remains a challenge – AP News

Obesity drug prices are dropping, but getting a steady supply remains a challenge  AP News Contributor: Here’s how to get GLP-1 drugs covered by employer health insurance  Los Angeles Times CVS dropped Zepbound in standard coverage. What that means for Zepbound users  IndyStar Insurance cutbacks on costly GLP-1 coverage are good for small businesses  The Boston Globe Major insurance […]

Eli Lilly’s 3-step strategy to dominate the $95 billion obesity market

Scientists at Eli Lilly are racing to develop new weight loss drugs that will be cheaper, stronger, or preserve more muscle mass. Eli Lilly Eli Lilly has outpaced Ozempic-maker Novo Nordisk in the race to develop new incretin drugs. The company is set to capture 50% of the $95 billion obesity market by 2050. We […]